TRIM56 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.389200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.296800E-01
Normal-vs-Stage2
7.114600E-01
Normal-vs-Stage3
3.153000E-01
Normal-vs-Stage4
4.916800E-01
Stage1-vs-Stage2
8.662600E-01
Stage1-vs-Stage3
4.917600E-02
Stage1-vs-Stage4
2.041800E-01
Stage2-vs-Stage3
8.11750000000444E-05
Stage2-vs-Stage4
7.991700E-02
Stage3-vs-Stage4
6.539900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.422200E-01
Normal-vs-AfricanAmerican
8.579400E-01
Normal-vs-Asian
5.031200E-01
Caucasian-vs-AfricanAmerican
7.408800E-01
Caucasian-vs-Asian
5.396800E-01
AfricanAmerican-vs-Asian
5.107400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.759800E-01
Normal-vs-Female
6.121200E-01
Male-vs-Female
6.459800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.690400E-01
Normal-vs-Age(41-60Yrs)
9.565000E-01
Normal-vs-Age(61-80Yrs)
5.003600E-01
Normal-vs-Age(81-100Yrs)
4.395200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.334400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.588600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.342200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.940000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.934960E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.142200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.613600E-01
Normal-vs-Daily Drinker
3.780000E-01
Normal-vs-Weekly Drinker
7.291000E-01
Normal-vs-Occasional Drinker
9.504000E-01
Normal-vs-Social Drinker
7.383800E-01
Non Drinker-vs-Daily Drinker
5.988600E-01
Non Drinker-vs-Weekly Drinker
6.931800E-01
Non Drinker-vs-Occasional Drinker
3.885600E-01
Non Drinker-vs-Social Drinker
3.156200E-02
Daily Drinker-vs-Weekly Drinker
4.735600E-01
Daily Drinker-vs-Occasional Drinker
2.540000E-01
Daily Drinker-vs-Social Drinker
1.898050E-02
Weekly Drinker-vs-Occasional Drinker
6.662000E-01
Weekly Drinker-vs-Social Drinker
2.327600E-01
Occasional Drinker-vs-Social Drinker
5.580400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.302380E-01
Normal-vs-Grade 2
1.754130E-02
Normal-vs-Grade 3
3.448300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.516300E-02
Grade 1-vs-Grade 3
2.116000E-03
Grade 1-vs-Grade 4
1.302380E-01
Grade 2-vs-Grade 3
8.895900E-03
Grade 2-vs-Grade 4
1.754130E-02
Grade 3-vs-Grade 4
3.448300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.891600E-01
Normal-vs-NonDiabetic
5.758400E-01
Diabetic-vs-NonDiabetic
3.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.631600E-01
Normal-vs-NoPancreatitis
5.547200E-01
Pancreatitis-vs-NoPancreatitis
9.210000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.816200E-01
Normal-vs-N1
7.228400E-01
N0-vs-N1
2.713600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.081400E-01
Normal-vs-TP53-NonMutant
8.871400E-01
TP53-Mutant-vs-TP53-NonMutant
9.439400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
